The Business Times
business-time-50
SUBSCRIBERS

Lonza in joint venture to develop biotherapeutic products

google-preferred-sourceAdd BT as a preferred source

Ng Ren Jye

Published Wed, Apr 3, 2019 · 09:50 PM

Singapore

SWISS biotech company Lonza has entered into an equal joint venture (JV) with Danish bioscience company Chr Hansen Holding to develop live biotherapeutic products (LBP) for pharma and biotech customers.

The phased investment of about 90 million euros (S$136.6 million) will be shared equally between the partners over three years.

lonza

TRENDING NOW

Household liabilities are growing faster than household assets, a shift that emerged in the fourth quarter of 2025 and continued through the first quarter of 2026.

Singapore households’ net wealth up, but also taking on more debt such as home loans

Ang Kiam Meng, group CEO and executive chairman of Jumbo Group, says the move to a bigger headquarters is necessary to future-proof the business.

With new S$10 million HQ, Jumbo Group looks to Shanghai-focused China strategy, premium dining for growth

Four projects housing 1,679 units will likely test buyer appetite in July.

Up to 11 new condo projects with 3,550 units lined up for H2 launch as price ceilings emerge

The departure of food manufacturing operations from Singapore may not necessarily be reason for concern.

Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More